His primary areas of study are Alzheimer's disease, Dementia, Internal medicine, Pathology and Cerebrospinal fluid. His Alzheimer's disease research incorporates themes from Biomarker, Central nervous system disease, Degenerative disease and Cognitive disorder. His research integrates issues of White matter and Neurology in his study of Dementia.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Oncology. His Cerebrospinal fluid study combines topics in areas such as Total tau, Amyloid beta and Immunology, Pathogenesis. Anders Wallin has researched Vascular dementia in several fields, including Cognition, Serum albumin and Cardiology.
Anders Wallin focuses on Dementia, Internal medicine, Alzheimer's disease, Cerebrospinal fluid and Pathology. His Dementia research includes elements of Central nervous system disease and Psychiatry, Cognition. Anders Wallin focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Endocrinology and, in certain cases, Homovanillic acid.
The Alzheimer's disease study combines topics in areas such as Apolipoprotein E, Cognitive disorder, Frontotemporal dementia and Degenerative disease. His Cerebrospinal fluid study incorporates themes from Albumin, Immunology, Pathogenesis and Amyloid. His Pathology course of study focuses on White matter and Hyperintensity.
His primary scientific interests are in Dementia, Internal medicine, Disease, Neuropsychology and Cognition. His work deals with themes such as Alzheimer's disease, Neurology, Cognitive impairment and Biomarker discovery, which intersect with Dementia. Cerebrospinal fluid and Vascular dementia are among the areas of Internal medicine where the researcher is concentrating his efforts.
His study on Disease is covered under Pathology. His Neuropsychology research is multidisciplinary, relying on both Audiology and Cognitive decline. His work is dedicated to discovering how Cognition, Clinical psychology are connected with Peer review and other disciplines.
Anders Wallin mainly investigates Dementia, Disease, Alzheimer's disease, Internal medicine and Cognition. His Dementia study combines topics from a wide range of disciplines, such as Psychiatry, Neurology, Vascular disease and Pediatrics. His Disease research focuses on Blood–brain barrier and how it connects with White matter.
Anders Wallin combines subjects such as Biomarker, Apolipoprotein E, Bioinformatics and Amyloid with his study of Alzheimer's disease. The various areas that Anders Wallin examines in his Internal medicine study include Magnetic resonance imaging, Oncology and Geriatrics. His studies deal with areas such as Vascular dementia, Clinical psychology and Cognitive decline as well as Cognition.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
L. O. Wahlund;F. Barkhof;F. Fazekas;L. Bronge.
Subcortical ischaemic vascular dementia
Gustavo C Román;Timo Erkinjuntti;Anders Wallin;Leonardo Pantoni.
Lancet Neurology (2002)
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
Research criteria for subcortical vascular dementia in clinical trials.
Timo Erkinjuntti;D. Inzitari;L. Pantoni;A. Wallin.
Journal of Neural Transmission-supplement (2000)
Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease
Niels Andreasen;Camilla Hesse;Pia Davidsson;Lennart Minthon.
JAMA Neurology (1999)
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
Magnus Sjögren;Hugo Vanderstichele;Hans Ågren;Olof Zachrisson.
Clinical Chemistry (2001)
Association of gait and balance disorders with age-related white matter changes The LADIS Study
H. Baezner;C. Blahak;A. Poggesi;L. Pantoni.
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
Elisabeth Tarkowski;Kaj Blennow;Anders Wallin;Andrzej Tarkowski.
Journal of Clinical Immunology (1999)
Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology
Annika Olsson;Hugo Vanderstichele;Niels Andreasen;Geert De Meyer.
Clinical Chemistry (2005)
Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and Methodology
Leonardo Pantoni;Anna Maria Basile;Giovanni Pracucci;Kjell Asplund.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: